Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability and Clinical Relevance in a Non-screened Population

about

Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability and Clinical Relevance in a Non-screened Population

Item

http://www.wikidata.org/entity/Q57123974

description

scientific article published on 21 August 2017

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Quality Indicators for Sentine ...... e in a Non-screened Population

@en

Quality Indicators for Sentine ...... e in a Non-screened Population

@nl

type

Item

label

Quality Indicators for Sentine ...... e in a Non-screened Population

@en

Quality Indicators for Sentine ...... e in a Non-screened Population

@nl

prefLabel

Quality Indicators for Sentine ...... e in a Non-screened Population

@en

Quality Indicators for Sentine ...... e in a Non-screened Population

@nl

P1476

Quality Indicators for Sentine ...... e in a Non-screened Population

@en

P2093

Indu Arun

http://www.w3.org/2001/XMLSchema#string

Nikhil Nalawade

http://www.w3.org/2001/XMLSchema#string

Rosina Ahmed

http://www.w3.org/2001/XMLSchema#string

Sachin Suresh Shenoy

http://www.w3.org/2001/XMLSchema#string

Sanjit Kumar Agrawal

http://www.w3.org/2001/XMLSchema#string

Sanjoy Chatterjee

http://www.w3.org/2001/XMLSchema#string

Soumendranath Roy

http://www.w3.org/2001/XMLSchema#string

P2860

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review.

Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.

Breast Cancer Care in India: The Current Scenario and the Challenges for the Future.

Review of sentinel lymph node credentialing: how many cases are enough?

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

Guidelines to assure quality in breast cancer surgery.

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

P2888

s13193-017-0695-5

P304

312-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13193-017-0695-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Soumitra S Datta

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30287989

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

6154378

http://www.w3.org/2001/XMLSchema#string